Literature DB >> 7839816

Benign mitochondrial myopathy with decreased succinate cytochrome C reductase activity.

J Arpa1, Y Campos, M Gutiérrez-Molina, A Cruz-Martínez, J Arenas, A B Caminero, F Palomo, C Morales, P Barreiro.   

Abstract

In most of the cases previously described, the defect on complex II was suggested by low activity of succinate cytochrome C reductase (SCCR). The clinical pattern of the previous 10 cases is heterogeneous and may be limited to one particular tissue or be of a more general nature. We report a 22-year-old-woman, daughter of consanguineous parents, with generalized muscle weakness, easy fatigability and benign course, who showed a decrease of SCCR activity in mitochondria of muscle fibers. Free carnitine (FC) concentration was decreased in muscle as well. The muscle biopsy showed a mild variation in fiber size, with fiber type I predominance, subsarcolemmal oxidative DPNH accumulations, excess of neutral lipids and abnormally large mitochondria with paracrystalline inclusions. A possible inheritance pattern is discussed. Coenzyme Q10 therapy in this patient induced a significant increase of global MRC index score and a decrease of the turns-mean amplitude ratio in the automatic analysis of the EMG.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7839816     DOI: 10.1111/j.1600-0404.1994.tb02722.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Benign mitochondrial encephalomyopathy in a patient with complex I deficiency.

Authors:  J M Trijbels; W Ruitenbeek; R C Sengers; A J Janssen; B A van Oost
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Respiratory complex II defect in siblings associated with a symptomatic secondary block in fatty acid oxidation.

Authors:  J J Gargus; K Boyle; M Bocian; D S Roe; C Vianey-Saban; C R Roe
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

3.  Pathological mechanisms underlying single large-scale mitochondrial DNA deletions.

Authors:  Mariana C Rocha; Hannah S Rosa; John P Grady; Emma L Blakely; Langping He; Nadine Romain; Ronald G Haller; Jane Newman; Robert McFarland; Yi Shiau Ng; Grainne S Gorman; Andrew M Schaefer; Helen A Tuppen; Robert W Taylor; Doug M Turnbull
Journal:  Ann Neurol       Date:  2018-01       Impact factor: 10.422

Review 4.  Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease.

Authors:  Abena Nsiah-Sefaa; Matthew McKenzie
Journal:  Biosci Rep       Date:  2016-02-02       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.